Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Wang, Xuan  [Clear All Filters]
Journal Article
Yang D, Wang ZQiong, Deng JQi, Liao JYuan, Wang X, Xie J, Deng MMing, Lv MHan. Adipose-Derived Stem Cells: A Candidate for Liver Regeneration. J Dig Dis. 2015.
Wang S, Wang N, Huang X, Yang B, Zheng Y, Zhang J, Wang X, Lin Y, Wang Z. Baohuoside i suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway. Phytomedicine. 2020;78:153331.
Shu T, Wu T, Pang M, Liu C, Wang X, Wang J, Liu B, Rong L. Effects and mechanisms of melatonin on neural differentiation of induced pluripotent stem cells. Biochem Biophys Res Commun. 2016.
Wu H, Wang X, Liang H, Zheng J, Huang S, Zhang D. Enhanced Efficacy of Propranolol Therapy for Infantile Hemangiomas based on a Mesoporous Silica Nanoplatform through Mediating Autophagy Dysfunction. Acta Biomater. 2020.
Wang X, Zheng F, Liu O, Zheng S, Liu Y, Wang Y, Tang Z, Zhong L. Epidermal growth factor can optimize a serum-free culture system for bone marrow stem cell proliferation in a miniature pig model. In Vitro Cell Dev Biol Anim. 2013.
Wang S, Wang X, Tan Z, Su Y, Liu J, Chang M, Yan F, Chen J, Chen T, Li C, et al. Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury. Cell Res. 2019.
Zhou Y, Yang W, Li Z, Luo D, Li W, Zhang Y, Wang X, Fang M, Chen Q, Jin X. Moringa oleifera stem extract protect skin keratinocytes against oxidative stress injury by enhancement of antioxidant defense systems and activation of PPARα. Biomed Pharmacother. 2018;107:44-53.
Liu C, Huang Y, Pang M, Yang Y, Li S, Liu L, Shu T, Zhou W, Wang X, Rong L, et al. Tissue-Engineered Regeneration of Completely Transected Spinal Cord Using Induced Neural Stem Cells and Gelatin-Electrospun Poly (Lactide-Co-Glycolide)/Polyethylene Glycol Scaffolds. PLoS One. 2015;10(3):e0117709.
Zhao Y, Liu Z, Wang X, Wu H, Zhang J, Yang J, Zhang F, Liu L, Long J, Lu P, et al. Treatment with humanized selective CD19CAR-T cells shows efficacy in highly treated B-ALL patients who have relapsed after receiving murine-based CD19CAR-T therapies. Clin Cancer Res. 2019.